Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients [Phase 3]
A Phase III trial evaluating the efficacy and safety of the GV1001-Gem/Cap regimen versus Gemcitabine/Capecitabine in pancreatic cancer, wit…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer [NA]
A terminated clinical trial evaluated splenectomy-omitting radical pancreatectomy in well-selected left-sided pancreatic cancer.
-
FDA approval · 2016-11-17FDA Approved: GEMCITABINE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for gemcitabine under ANDA 079183. This represents approval of a supplemental submissi…
-
CLINICAL_TRIALS research · 2016-11-08Clinical Trial Update: A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy [Phase 1, Phase 2]
This document updates a Phase 1/Phase 2 clinical trial evaluating CAR-T cell therapy combined with interventional therapy for advanced liver…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating selumetinib with erlotinib in locally advanced or metastatic pancreatic cancer has completed with results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-11-03Clinical Trial Update: Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy [NA]
A clinical trial update investigating a proximal Roux-en-Y gastrojejunal anastomosis to address delayed gastric emptying after pylorus-resec…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC5754A administered intravenously in patients with platinum-resistant ovarian…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial of capecitabine (Xeloda) in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer [Phase 4]
A Phase 4 clinical trial update assessing a COX-2 inhibitor for adjuvant anticancer effects in bile duct cancer and pancreatic cancer; curre…
-
CLINICAL_TRIALS other · 2016-10-26Clinical Trial Update: Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer [Phase 4]
Clinical trial update for a Phase 4 study comparing nimotuzumab plus S-1 versus placebo plus S-1 as maintenance therapy in unresectable panc…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi [Phase 4]
Phase 4 trial comparing covered self-expandable metallic stents (SEMS) above vs. across the Sphincter of Oddi in bile duct cancer and pancre…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Sirolimus in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating sirolimus for advanced pancreatic cancer has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy [NA]
A randomized trial comparing pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy has completed…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial investigated a four-drug combination of erlotinib, bevacizumab, gemcitabine, and capecitabine for advanced pancr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) [Phase 2]
Phase 2 PERU trial evaluating UFT/Leucovorin with radiotherapy with or without cetuximab after induction gemcitabine plus capecitabine in lo…
-
CLINICAL_TRIALS withdrawal · 2016-10-07Clinical Trial Update: Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer [NA]
Compassionate single-subject use of pamrevlumab (FG-3019) for locally advanced, unresectable pancreatic cancer has been withdrawn from the s…
-
FDA approval · 2016-10-06FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)
FDA Supplemental Application for PERTZYE (pancrelipase) submitted by Digestive Care, Inc. under BLA022175. The submission pertains to a supp…
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma [Phase 2]
A Phase 2 safety trial of adjuvant gemcitabine after laparoscopic distal pancreatectomy for pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy [Phase 1]
Phase 1 safety study of 212Pb-TCMC-Trastuzumab radioimmunotherapy has completed, evaluating safety in multiple HER2-expressing cancers. The …
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]
Phase 1, single-dose pilot study evaluating radiolabeled amatuximab (MORAb-009) in mesothelin-overexpressing cancers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating the efficacy and safety of PBI-05204 in patients with stage IV metastatic p…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Endoscopic Drainage of Collections After Pancreatic Surgery
This clinical trial update describes endoscopic drainage of postoperative collections after pancreatic surgery in pancreatic cancer patients…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer [Phase 2]
Phase II study evaluating gemcitabine plus erlotinib as adjuvant therapy for resected pancreatic cancer was terminated; results have been po…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Use of PET Imaging to Distinguish Malignant From Benign IPMN [NA]
Terminated clinical trial evaluating whether PET imaging can distinguish malignant from benign intraductal papillary mucinous neoplasms of t…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer [NA]
A completed clinical trial comparing multicolour versus monocolour inking after pancreaticoduodenectomy for periampullary cancer. Sponsor: I…